Dana E. Moseson

1.1k citations
27 papers · 852 · 1 hit paper · h-index 18

Impact in

Papers in

Dana E. Moseson

27 papers receiving 838 citations

Dana E. Moseson's Hit Papers

Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023 2024 · 55 citations
550+1Years since publication1020304050

Peers

Dana E. Moseson
Comparison fields: 5 of 91
  • Pharmaceutical Science 564
  • Analytical Chemistry 87
  • Materials Chemistry 408
  • Spectroscopy 117
  • Civil and Structural Engineering 85
Replace Jing Tao with:
Jing Tao China
Jiannan Lu United States
P. Sakellariou United Kingdom
H Nyqvist Sweden
Michael Juhnke Switzerland
Shaun Fitzpatrick United Kingdom
Dilbir S. Bindra United States
Azzeddine Lekhal United States
E. Kougoulos United Kingdom
Niels Erik Olesen Denmark
Dana E. Moseson relative to Jing Tao China Jing Tao's profile →
Citations per field
00.5×10.6×
Jing Tao · 1×
Citations per year

Countries citing papers authored by Dana E. Moseson

Since Specialization
Citations

This map shows the geographic impact of Dana E. Moseson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana E. Moseson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana E. Moseson more than expected).

Fields of papers citing papers by Dana E. Moseson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana E. Moseson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana E. Moseson. The network helps show where Dana E. Moseson may publish in the future.

Co-authors

The 25 scholars most cited alongside Dana E. Moseson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dana E. Moseson Line = papers co-authored together Dana E. Moseson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#Work
1 201189
2 202081
3 201879
4 202156
5 202055
6
Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023
Hit paper breakdown →
202455
7 202052
8 201948
9 202143
10 202432
11 202127
12 202224
13 202324
14 202222
15 201922
16 201821
17 202219
18 202118
19 202116
20 202316

About Dana E. Moseson

Dana E. Moseson is a scholar working on Pharmaceutical Science, Materials Chemistry, Molecular Biology, Analytical Chemistry and Biomedical Engineering, having authored 27 papers that have together received 852 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (22 papers), Crystallization and Solubility Studies (15 papers), Protein purification and stability (8 papers), Analytical Methods in Pharmaceuticals (4 papers), Advanced Drug Delivery Systems (3 papers), Analytical Chemistry and Chromatography (3 papers), Nanoparticle-Based Drug Delivery (2 papers) and Analytical chemistry methods development (2 papers). The work is most often cited by research in Pharmaceutical Science (564 citations), Analytical Chemistry (87 citations), Materials Chemistry (408 citations), Spectroscopy (117 citations) and Civil and Structural Engineering (85 citations). Dana E. Moseson has collaborated with scholars based in United States, Belgium and Japan. Frequent co-authors include Lynne S. Taylor, Sugandha Saboo, Umesh S. Kestur, Alexander J. Moseson, Michel W. Barsoum, Tze Ning Hiew, Keisuke Ueda, Stephen P. Beaudoin, Andrew S. Parker and Patrick Augustijns. Their work appears in journals such as Molecular Pharmaceutics, Journal of Pharmaceutical Sciences, Crystal Growth & Design, International Journal of Pharmaceutics and European Journal of Pharmaceutical Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact